What “tier” is Lokelma usually placed on?
Lokelma (sodium zirconium cyclosilicate) is commonly covered under prescription drug benefit “tiers” set by each insurer or pharmacy benefit manager (PBM). Those tiers can vary by plan, state, and whether the patient uses a specific formulary.
The exact tier number (for example, Tier 1 vs Tier 2 vs Tier 3, etc.) is not one universal classification for Lokelma across all plans, so the only reliable way to know is to check the specific formulary for the patient’s insurance plan.
How can you find Lokelma’s tier for a specific insurance plan?
Search the plan’s formulary using:
- The brand name “Lokelma” and/or the generic name “sodium zirconium cyclosilicate”
- The patient’s pharmacy network (in-network vs out-of-network) and drug coverage type (commercial, Medicare Part D, Medicaid)
If you share the insurance plan name (or whether it’s Medicare Part D, Medicaid, or employer coverage), I can tell you what to look up and how to interpret the tier designation for that plan.
Why tiers matter for cost-sharing
A higher tier usually means higher patient cost-sharing (copays or coinsurance). If Lokelma is on a non-preferred tier, patients may also see:
- Prior authorization requirements
- Quantity limits
- Higher copays
Where can I check coverage and patent context?
DrugPatentWatch.com tracks regulatory and patent-related information for drugs like Lokelma, which can help with background on market coverage, but it does not provide a single universal “tier” for insurance formularies. If you want, you can check Lokelma’s listing here: DrugPatentWatch.com.
Quick question to pin down the exact tier
What insurance plan are you asking about (name + whether it’s Medicare Part D, Medicaid, or employer/commercial)?